Published in Infect Disord Drug Targets on April 01, 2010
Immunity, atherosclerosis and cardiovascular disease. BMC Med (2013) 1.49
Common infections and the risk of stroke. Nat Rev Neurol (2010) 1.29
Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis (2011) 1.00
Immune mechanisms in atherosclerosis, especially in diabetes type 2. Front Endocrinol (Lausanne) (2013) 0.94
Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis. J Oral Microbiol (2014) 0.87
Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System. Int J Alzheimers Dis (2011) 0.84
ROCKs as immunomodulators of stroke. Expert Opin Ther Targets (2012) 0.84
In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome (2015) 0.83
Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol (2012) 0.81
A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol (2015) 0.79
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol (2016) 0.77
Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health (2016) 0.76
Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay. PLoS One (2015) 0.75
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med (2002) 6.00
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA (2003) 4.44
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med (2005) 4.13
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet (1993) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med (2000) 3.82
Azithromycin for the secondary prevention of coronary events. N Engl J Med (2005) 3.42
Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation (2002) 3.20
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation (2003) 3.15
Periodontal disease and coronary heart disease risk. JAMA (2000) 2.96
Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med (1996) 2.72
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun (1996) 2.52
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation (1999) 2.36
Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A (1983) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med (2006) 2.17
Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol (1998) 2.12
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Endothelial dysfunction in childhood infection. Circulation (2005) 1.97
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA (2002) 1.95
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation (2000) 1.92
Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart (2007) 1.90
High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol (1990) 1.78
Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke (2001) 1.76
Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke (2006) 1.70
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb (1992) 1.59
Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol (2001) 1.58
Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Med (Hagerstown) (2009) 1.57
A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med (2000) 1.52
Impact of infectious burden on progression of carotid atherosclerosis. Stroke (2002) 1.40
Possible role of cytomegalovirus in atherogenesis. JAMA (1990) 1.39
Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke (1998) 1.39
Insights into the role of infection in atherogenesis and in plaque rupture. Circulation (2009) 1.39
Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation (2006) 1.28
Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. Stroke (2000) 1.26
Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. Stroke (1999) 1.20
Simvastatin prevents vascular hyporeactivity during inflammation. Circulation (2004) 1.20
Herpesvirus-induced atherosclerosis in chickens. Fed Proc (1983) 1.17
Influenza vaccination is associated with a reduced risk of stroke. Stroke (2005) 1.10
Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J (2008) 1.10
Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation (2003) 1.06
Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med (2000) 1.05
Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity? Am J Hum Genet (1998) 1.02
Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation (2003) 1.01
Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vasc Biol (2005) 1.00
Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis (1995) 0.96
Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J Periodontol (2005) 0.95
Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J (2003) 0.95
Cardiac allograft vasculopathy: current concepts. Am Heart J (1995) 0.94
Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation (2001) 0.91
Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke (2004) 0.91
Association of symptoms of chronic bronchitis and frequent flu-like illnesses with stroke. Stroke (2009) 0.90
Serum IgG and IgA antibodies to Chlamydia in ectopic pregnancies. Contraception (1989) 0.87
Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun (2008) 0.87
Infection-associated intimal thickening in the coronary arteries of children. Atherosclerosis (1999) 0.84
Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke (2001) 0.84
Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol (2002) 0.83
The effects of metabolic syndrome versus infectious burden on inflammation, severity of coronary atherosclerosis, and major adverse cardiovascular events. J Clin Endocrinol Metab (2007) 0.81
Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke. Cerebrovasc Dis (2003) 0.79
Pathogen burden and cortisol profiles over the day. Epidemiol Infect (2009) 0.78
Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke (2010) 1.14
Reflections: neurology and the humanities. If I had time. Neurology (2009) 0.75